Results 201 to 210 of about 22,483 (254)
Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan. [PDF]
de Castro C +14 more
europepmc +1 more source
C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria. [PDF]
Rodríguez de Córdoba S +8 more
europepmc +1 more source
Paroxysmal nocturnal hemoglobinuria masquerading as hemolytic uremic syndrome: a Case Report. [PDF]
Gao M, Liu B, Yao J, Huang F.
europepmc +1 more source
Ravulizumab exposure in early pregnancy. [PDF]
Füreder W, Granser S, Repa A, Farr A.
europepmc +1 more source
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study. [PDF]
D'Addio A +19 more
europepmc +1 more source
Clinical Spectrum of Hemolytic Anemia in Loxoscelism: Report of Two Cases Highlighting Variable Severity and Management. [PDF]
Al-Sadi A +4 more
europepmc +1 more source

